Under a new collaborative research agreement, Astellas Pharma is turning to an interesting choice of partner to develop a novel antibody-drug conjugate platform for oncology therapeutics. Tuesday, the Tokyo-based biopharma announced a collaboration with tech giant Sony Corporation.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,